Show simple item record

dc.contributor.authorZhou, Jun
dc.contributor.authorYi-Ting, Tsai
dc.contributor.authorWeng, Hong
dc.contributor.authorTang, Ewin N.
dc.contributor.authorNair, Ashwin
dc.contributor.authorDigant, Dave P.
dc.contributor.authorTang, Liping
dc.date.accessioned2014-08-13T15:31:35Z
dc.date.available2014-08-13T15:31:35Z
dc.date.issued2012-04-19
dc.identifier.citationPublished in International Journal of Nanomedicine 7:2057–2068,2012en_US
dc.identifier.issnISSN: 1176-9114
dc.identifier.issnESSN: 1178-2013
dc.identifier.urihttp://hdl.handle.net/10106/24540
dc.description.abstractNeutrophils play an important role in implant-mediated inflammation and infection. Unfortunately, current methods which monitor neutrophil activity, including enzyme measurements and histological evaluation, require many animals and cannot be used to accurately depict the dynamic cellular responses. To understand the neutrophil interactions around implant-mediated inflammation and infection it is critical to develop methods which can monitor in vivo cellular activity in real time. In this study, formyl peptide receptor (FPR)-targeting nearinfrared nanoprobes were fabricated. This was accomplished by conjugating near-infrared dye with specific peptides having a high affinity to the FPRs present on activated neutrophils. The ability of FPR-targeting nanoprobes to detect and quantify activated neutrophils was assessed both in vitro and in vivo. As expected, FPR-targeting nanoprobes preferentially accumulated on activated neutrophils in vitro. Following transplantation, FPR-targeting nanoprobes preferentially accumulated at the biomaterial implantation site. Equally important, a strong relationship was observed between the extent of fluorescence intensity in vivo and the number of recruited neutrophils at the implantation site. Furthermore, FPR-targeting nanoprobes may be used to detect and quantify the number of neutrophils responding to a catheter-associated infection. The results show that FPR-targeting nanoprobes may serve as a powerful tool to monitor and measure the extent of neutrophil responses to biomaterial implants in vivo.
dc.language.isoen_USen_US
dc.publisherDove pressen_US
dc.subjectIn vivo imagingen_US
dc.subjectNanoprobeen_US
dc.subjectNeutrophilsen_US
dc.subjectInflammationen_US
dc.subjectBiocompatibilityen_US
dc.titleReal-time detection of implant-associated neutrophil responses using a formyl peptide receptor-targeting NIR nanoprobeen_US
dc.typeArticleen_US
dc.publisher.departmentDepartment of Bioengineering, The University of Texas at Arlingtonen_US
dc.identifier.externalLinkDescriptionThe original publication is available at the Article DOIen_US
dc.identifier.doihttp://dx.doi.org/10.2147/IJN.S29961


Files in this item

Thumbnail


This item appears in the following Collection(s)

Show simple item record